About our client
Liminatus Pharma, LLC (“Company” or “Liminatus”) is pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies.
About our client
Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens.
About our client
Gritstone bio, Inc. (the “Company”) was a clinical-stage biotechnology company that aimed to develop the world’s most cutting-edge vaccines.
About our client
Stragen Services is a lyon-based pharmacovigilance and clinical safety services provider and has established itself as a reliable partner for the European Pharma, Biotech, and Medtech community.
About our client
Veru is a late clinical-stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases and oncology.
About our client
Lomond Therapeutics is a biopharmaceutical company, focused on the development of best-in-class and first-in-class small molecule inhibitors that target escape mutations in hematologic and solid cancers.
About our client
ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies. Based on its unique proprietary RNA repair platform technologies ProQR is growing its pipeline with patients and loved ones in mind.
About our client
Legacy Pharma Solutions is a leading pharmaceutical contract packager, offering comprehensive solutions to its blue-chip customer base, which include pharmaceutical manufacturers, retail pharmacy chains, and pharmaceutical wholesalers.
About our client
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need.
About our client
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need.
About our client
Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases.
About our client
Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients.
About our client
Avidity Biosciences, Inc.'s mission is to profoundly improve people's lives by delivering a new class of RNA therapeutics - Antibody Oligonucleotide Conjugates (AOCs™).
About our client
Aeterna is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of significant unmet medical need.
About our client
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.
About our client
Pacira is a commercial biopharmaceutical company focused on developing, manufacturing and marketing non-opioid pain management solutions.
About our client
Societal CDMO is a contract development and manufacturing organization with capabilities spanning pre-Investigational New Drug development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules.
About our client
Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need.
About our client
BridgeBio is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers.
About our client
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for the treatment of metabolic and endocrine disorders, with three compounds currently in clinical trials.
About our client
Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for CNS disorders.
About our client
Dianthus Therapeutics is a biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies.
About our client
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.
About our client
Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology ELUTYX™.
About our client
Bluebird bio is a biotechnology company committed to researching, developing, and commercializing potentially curative transformative gene therapies for severe genetic diseases based on their lentiviral vector (LVV) gene addition platform.
About our client
Veru Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology and viral-induced acute respiratory distress syndrome.
About our client
Visant Medical focuses on the treatment of dry eye disease. The Company's FDA cleared medical device, LACRIFILL®, is indicated to help patients experiencing dry eye symptoms by blocking tear drainage through occlusion of the canalicular system.
About our client
Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases.
About our client
89bio is a clinical-stage biopharmaceutical company dedicated to the development of therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options.
About our client
Novan, Inc. is a commercial stage specialty dermatology company based in Durham, NC. The Company utilizes its proprietary Nitricil platform, which facilitates the stabilization and delivery of nitric oxide (NO), to research and develop novel therapeutics for the treatment of skin diseases.
About our client
Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team of 85 employees and operations in the U.S., India and Europe.
About our client
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies.
About our client
Dianthus Therapeutics is a biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency over existing complement therapies.
About our client
VBI Vaccines Inc. is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease.
About our client
RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue.
About our client
PLx Pharma Inc. is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE®, an FDA-approved liquid-filled aspirin capsule, available in 81 mg and 325 mg doses.
About our client
Adamis Pharmaceuticals Corporation was a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose and allergy.
About our client
Nielsen BioSciences is a privately held biotechnology company based in San Diego and founded in 2013.
About our client
InflaRx is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
About our client
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders, with three compounds currently in clinical trials.
About our client
89bio is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases.
About our client
Zura is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab.
About our client
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
About our client
Sol-Gel is a dermatology company focused on identifying, developing and commercializing or partnering topical drug products for the treatment of skin diseases.
About our client
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on improving the lives of people with liver and other chronic diseases that have high unmet medical need through a pipeline of innovative therapies.
About our client
Based in Parma, Italy, Chiesi is an international research-focused pharmaceuticals and healthcare group with over 85 years' experience, operating in 30 countries with more than 6,000 employees.
About our client
Avidity Biosciences, Inc.'s mission is to profoundly improve people's lives by delivering a new class of RNA therapeutics - Antibody Oligonucleotide Conjugates.
About our client
Myrtelle Inc. is a gene therapy company focused on developing transformative treatments for neurodegenerative diseases.
